AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23531329 — intervention group
Group type: EXPERIMENTAL
Intervention: Eicosapentaenoic acid supplementation
Number of subjects: 126
Study 23531329 — intervention group
Group type: EXPERIMENTAL
Intervention: Docosahexaenoic acid supplementation
Number of subjects: 126
Study 23531329 — intervention group
Group type: COMPARATOR
Intervention: Cesarean delivery
Number of subjects: 126
Study 20958277 — intervention group
Group type: EXPERIMENTAL
Intervention: ropivacaine 0.25%
Number of subjects: 48
Study 20958277 — intervention group
Group type: COMPARATOR
Intervention: saline infusion
Number of subjects: 48
Study 17965109 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal triamcinolone acetonide (4 mg/0.1 ml)
Number of subjects: 28
Study 17965109 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab (1.5 mg/0.06 ml)
Number of subjects: 28
Study 17030525 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV behavioural intervention
Number of subjects: 1277
Study 12942187 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride for male pattern hair loss
Number of subjects: 0
Study 12942187 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser-assisted hair removal systems for hypertrichosis and hirsutism
Number of subjects: 0
Study 12942187 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 17α-estradiol
Number of subjects: 0
Study 12942187 — intervention group
Group type: COMPARATOR
Intervention: Topical minoxidil
Number of subjects: 0
Study 12942187 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical immunotherapy for alopecia areata
Number of subjects: 0
Study 12942187 — intervention group
Group type: EXPERIMENTAL
Intervention: Modern broad spectrum antimycotic agents for infectious scarring alopecias
Number of subjects: 0
Study 11012956 — intervention group
Group type: EXPERIMENTAL
Intervention: ketorolac 0.5% ophthalmic solution
Number of subjects: 30
Study 11012956 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study 9001827 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluticasone propionate nasal spray 200 micrograms once daily (n = 77)
Number of subjects: 304
Study 9001827 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fluticasone propionate 5 mg once daily (n = 73)
Number of subjects: 304
Study 9001827 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fluticasone propionate 10 mg once daily (n = 77)
Number of subjects: 304
Study 9001827 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 77)
Number of subjects: 304
Study 1282613 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine (50 micrograms intracoronary)
Number of subjects: 20
Study 1282613 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem (500 micrograms intracoronary)
Number of subjects: 20
Study 1282613 — intervention group
Group type: EXPERIMENTAL
Intervention: SIN-1 (500 micrograms intracoronary)
Number of subjects: 20
Study 1282613 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 6374932 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucralfate
Number of subjects: 0
Study 31577081 — intervention group
Group type: EXPERIMENTAL
Intervention: i.v. combination of ampicillin + sulbactam with daily cleaning of tonsillar lesions
Number of subjects: 2
Study 31577081 — intervention group
Group type: COMPARATOR
Intervention: i.v. combination of ampicillin + sulbactam
Number of subjects: 2
Study 29030111 — intervention group
Group type: EXPERIMENTAL
Intervention: LFMS treatment (20 min/day for 4 days)
Number of subjects: 84
Study 29030111 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (20 min/day for 4 days)
Number of subjects: 84
Study 29030111 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment (20 min/day for 2 days followed by LFMS treatment 20 min/day for 2 days)
Number of subjects: 84
Study 27639997 — intervention group
Group type: EXPERIMENTAL
Intervention: Group C (fragile oocytes)
Number of subjects: 0
Study 27639997 — intervention group
Group type: COMPARATOR
Intervention: Group A (normal oocytes, no fragile oocytes)
Number of subjects: 0
Study 27639997 — intervention group
Group type: COMPARATOR
Intervention: Group B (normal oocytes, at least one fragile oocyte)
Number of subjects: 0
Study 27639997 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups (including Group C)
Number of subjects: 0
Study 25298321 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg yohimbine
Number of subjects: 50
Study 25298321 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 23094034 — intervention group
Group type: EXPERIMENTAL
Intervention: Booklet combined with a short ICF
Number of subjects: 282
Study 23094034 — intervention group
Group type: EXPERIMENTAL
Intervention: Booklet combined with a simplified ICF
Number of subjects: 282
Study 23094034 — intervention group
Group type: COMPARATOR
Intervention: Standard ICF
Number of subjects: 282
Study 23094034 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified ICF
Number of subjects: 282
Study 21175018 — intervention group
Group type: EXPERIMENTAL
Intervention: Indirectly bonded brackets with methyl methacrylate monomer (MMM) conditioned custom bases
Number of subjects: 36
Study 21175018 — intervention group
Group type: COMPARATOR
Intervention: Indirectly bonded brackets without conditioning (Control group)
Number of subjects: 36
Study 17981189 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesh repair
Number of subjects: 300
Study 17981189 — intervention group
Group type: COMPARATOR
Intervention: Non-mesh repair
Number of subjects: 300
Study 14693772 — intervention group
Group type: EXPERIMENTAL
Intervention: lyophilisate (68 microg fluorescein SE 0.17%)
Number of subjects: 20
Study 14693772 — intervention group
Group type: COMPARATOR
Intervention: preservative free eye drop (40 microg)
Number of subjects: 20
Study 14693772 — intervention group
Group type: EXPERIMENTAL
Intervention: lyophilisate
Number of subjects: 20
Study 11990727 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonograph muscle thickness measurements
Number of subjects: 46
Study 11990727 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple regression equation
Number of subjects: 46
Study 11990727 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple regression equation
Number of subjects: 46
Study 9830243 — intervention group
Group type: EXPERIMENTAL
Intervention: SocAnh group (n = 34)
Number of subjects: 173
Study 9830243 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 139)
Number of subjects: 173
Study 7862876 — intervention group
Group type: EXPERIMENTAL
Intervention: Sumatriptan (6 mg subcutaneously)
Number of subjects: 11
Study 7862876 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 2510191 — intervention group
Group type: EXPERIMENTAL
Intervention: L-Carnitina (1 g endovenous, per orally administered vials, tablets)
Number of subjects: 110
Study 2510191 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study 31897572 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment (alcohol, hypnotics, sleep deprivation)
Number of subjects: 315
Study 31897572 — intervention group
Group type: COMPARATOR
Intervention: Baseline SDLP
Number of subjects: 315
Study 31897572 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment-induced changes in SDLP
Number of subjects: 315
Study 29984800 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading of the tympanic membrane with 340 mg (25 λ)
Number of subjects: 60
Study 29984800 — intervention group
Group type: EXPERIMENTAL
Intervention: Loading of the tympanic membrane with 544 mg (40 λ)
Number of subjects: 60
Study 29984800 — intervention group
Group type: COMPARATOR
Intervention: Control (no loading)
Number of subjects: 60
Study 27657799 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac web-based eLearning platform in addition to conventional cardiac care
Number of subjects: 1000
Study 27657799 — intervention group
Group type: COMPARATOR
Intervention: Conventional cardiac care alone
Number of subjects: 1000
Study 25200170 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric Rehabilitation Service (BRS) - three 50-min one-to-one sessions with a health psychologist
Number of subjects: 162
Study 25200170 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 162
Study 23623861 — intervention group
Group type: EXPERIMENTAL
Intervention: Humanoid robot interaction during vaccination
Number of subjects: 57
Study 23623861 — intervention group
Group type: COMPARATOR
Intervention: Standard administration procedures without robot
Number of subjects: 57
Study 20850390 — intervention group
Group type: COMPARATOR
Intervention: Intradiscal injection of normal saline
Number of subjects: 120
Study 20850390 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradiscal injection of diprospan
Number of subjects: 120
Study 20850390 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradiscal injection of diprospan+songmeile
Number of subjects: 120
Study 19225122 — intervention group
Group type: EXPERIMENTAL
Intervention: 2000 IU/d vitamin D supplementation
Number of subjects: 55
Study 19225122 — intervention group
Group type: EXPERIMENTAL
Intervention: 1000 IU/d vitamin D supplementation
Number of subjects: 55
Study 19225122 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 IU/d vitamin D supplementation
Number of subjects: 55
Study 19225122 — intervention group
Group type: COMPARATOR
Intervention: Control group (no supplements or own supplements)
Number of subjects: 55
Study 16472562 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous oral contraceptive (OC) use
Number of subjects: 36
Study 16472562 — intervention group
Group type: COMPARATOR
Intervention: Conventional oral contraceptive (OC) use
Number of subjects: 36
Study 16472562 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-OC discontinuation
Number of subjects: 36
Study 14517547 — intervention group
Group type: EXPERIMENTAL
Intervention: Mail intervention
Number of subjects: 1801
Study 14517547 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone intervention
Number of subjects: 1801
Study 14517547 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1801
Study 10920614 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycobacterium w antileprosy vaccine
Number of subjects: 157
Study 10920614 — intervention group
Group type: COMPARATOR
Intervention: Placebo injection
Number of subjects: 157
Study 8847984 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnetic fields (ELF‐MF) therapy, 20 procedures using Aplhatron 4100 device
Number of subjects: 96
Study 8847984 — intervention group
Group type: COMPARATOR
Intervention: Simulated treatment (control group of 29 sawyers)
Number of subjects: 96
Study 1575065 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpheniramine, 8 mg twice daily
Number of subjects: 1
Study 1575065 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorpheniramine, 12 mg twice daily
Number of subjects: 1
Study 1575065 — intervention group
Group type: EXPERIMENTAL
Intervention: Terfenadine, 120 mg twice daily
Number of subjects: 1
Study 1575065 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1
Study 1575065 — intervention group
Group type: EXPERIMENTAL
Intervention: Astemizole, 10 mg/d
Number of subjects: 1
Study 3886709 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin alone
Number of subjects: 9
Study 3886709 — intervention group
Group type: EXPERIMENTAL
Intervention: Digoxin with ethmozine
Number of subjects: 9
Study 3886709 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethmozine alone
Number of subjects: 9
Study 3886709 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethmozine with digoxin
Number of subjects: 9
Study 31392207 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage teaching technique
Number of subjects: 0
Study 31392207 — intervention group
Group type: COMPARATOR
Intervention: Four-stage teaching technique
Number of subjects: 0
Study 29320655 — intervention group
Group type: EXPERIMENTAL
Intervention: Frozen embryo transfer
Number of subjects: 782
Study 29320655 — intervention group
Group type: COMPARATOR
Intervention: Fresh embryo transfer
Number of subjects: 782
Study 26885791 — intervention group
Group type: EXPERIMENTAL
Intervention: Herbal-based cosmeceutical regimen (novel herbal blend)
Number of subjects: 110
Study 26885791 — intervention group
Group type: COMPARATOR
Intervention: Common antiaging topical treatments (prescription tretinoin, idebenone, kinetin, polyhydroxy, lactic and glycolic acids)
Number of subjects: 110
Study 24057990 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamphlet
Number of subjects: 135
Study 24057990 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamphlet/benefit statement
Number of subjects: 135
Study 24057990 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 135
Study 24057990 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamphlet and Pamphlet/benefit statement
Number of subjects: 135
Study 22933237 — intervention group
Group type: EXPERIMENTAL
Intervention: Aripiprazole 10 mg/day
Number of subjects: 39
Study 22933237 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study 20040167 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice nurse group
Number of subjects: 701
Study 20040167 — intervention group
Group type: COMPARATOR
Intervention: GP group
Number of subjects: 701
Study 19138428 — intervention group
Group type: EXPERIMENTAL
Intervention: Regression-based methods for adjusting publication bias
Number of subjects: 0
Study 19138428 — intervention group
Group type: COMPARATOR
Intervention: Trim & Fill algorithm
Number of subjects: 0
Study 16261600 — intervention group
Group type: EXPERIMENTAL
Intervention: Chocolate deprivation
Number of subjects: 103
Study 16261600 — intervention group
Group type: COMPARATOR
Intervention: Vanilla deprivation
Number of subjects: 103
Study 16261600 — intervention group
Group type: COMPARATOR
Intervention: Nondeprivation
Number of subjects: 103
Study 12153623 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary closure
Number of subjects: 240
Study 12153623 — intervention group
Group type: COMPARATOR
Intervention: Colostomy
Number of subjects: 240
Study 10623364 — intervention group
Group type: EXPERIMENTAL
Intervention: H2‐receptor antagonist maintenance therapy with ranitidine (150 mg daily)
Number of subjects: 119
Study 10623364 — intervention group
Group type: COMPARATOR
Intervention: H. pylori eradication therapy using an omeprazole/amoxicillin/metronidazole regimen
Number of subjects: 119
Study 7582388 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin (500 mg on day 1 and 250 mg on days 2-5)
Number of subjects: 10
Study 2275351 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up group
Number of subjects: 0
Study 2275351 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-section sample
Number of subjects: 0
Study 2275351 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up group (boys only)
Number of subjects: 0
Study 2275351 — intervention group
Group type: EXPERIMENTAL
Intervention: Cross-section sample (boys only)
Number of subjects: 0
Study 2275351 — intervention group
Group type: EXPERIMENTAL
Intervention: Follow-up group (girls)
Number of subjects: 0
Study 6893819 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg pirenzepine
Number of subjects: 43
Study 6893819 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg pirenzepine
Number of subjects: 43
Study 6893819 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg atropine
Number of subjects: 43
Study 6893819 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg atropine
Number of subjects: 43
Study 29777332 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 Hz tetanic stimulus (S group)
Number of subjects: 50
Study 29777332 — intervention group
Group type: COMPARATOR
Intervention: No tetanic stimulus (C group)
Number of subjects: 50
Study 29777332 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 50
Study 28359431 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention based on the McGill Model of Nursing
Number of subjects: 66
Study 28359431 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 66
Study 25495878 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric citrate (FC)
Number of subjects: 0
Study 25495878 — intervention group
Group type: COMPARATOR
Intervention: Active control (AC)
Number of subjects: 0
Study 22519696 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational intervention (personalized cardiovascular disease risk information) + QBE manipulation (completing a questionnaire about diet)
Number of subjects: 0
Study 22519696 — intervention group
Group type: COMPARATOR
Intervention: Motivational intervention (personalized cardiovascular disease risk information)
Number of subjects: 0
Study 22519696 — intervention group
Group type: COMPARATOR
Intervention: QBE intervention (completing a questionnaire about diet)
Number of subjects: 0
Study 22519696 — intervention group
Group type: COMPARATOR
Intervention: Neither intervention (control group)
Number of subjects: 0
Study 21587091 — intervention group
Group type: EXPERIMENTAL
Intervention: Narrow-band imaging (NBI) hysteroscopy
Number of subjects: 801
Study 21587091 — intervention group
Group type: COMPARATOR
Intervention: White light (WL) hysteroscopy
Number of subjects: 801
Study 18788415 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin‐converting enzyme inhibitors and angiotensin receptor blockers
Number of subjects: 0
Study 16931462 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving coping (women)
Number of subjects: 1287
Study 16931462 — intervention group
Group type: EXPERIMENTAL
Intervention: Avoidant coping (men)
Number of subjects: 1287
Study 12757528 — intervention group
Group type: EXPERIMENTAL
Intervention: RBCs without buffy coat (PC)
Number of subjects: 404
Study 12757528 — intervention group
Group type: EXPERIMENTAL
Intervention: WBC-reduced RBCs filtered before storage (FF)
Number of subjects: 404
Study 12757528 — intervention group
Group type: EXPERIMENTAL
Intervention: WBC-reduced RBCs filtered after storage (SF)
Number of subjects: 404
Study 10672842 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoprolol 100 mg given 2 hours before ERCP
Number of subjects: 38
Study 10672842 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 9419072 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal subjects with active righting
Number of subjects: 0
Study 9419072 — intervention group
Group type: COMPARATOR
Intervention: Normal subjects with passive righting
Number of subjects: 0
Study 9419072 — intervention group
Group type: EXPERIMENTAL
Intervention: Labyrinthine-defective (LD) subjects with active righting
Number of subjects: 0
Study 9419072 — intervention group
Group type: COMPARATOR
Intervention: Labyrinthine-defective (LD) subjects with passive righting
Number of subjects: 0
Study 1603291 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxiracetam 800 mg b.i.d. for 90 days
Number of subjects: 60
Study 1603291 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxiracetam 800 mg b.i.d. for 1 year (open follow-up)
Number of subjects: 60
Study 1603291 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 1603291 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxiracetam 800 mg b.i.d. during late follow-up
Number of subjects: 60
Study 3885675 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 17
Study 3885675 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 31622740 — intervention group
Group type: EXPERIMENTAL
Intervention: PENFS
Number of subjects: 50
Study 31622740 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 50
Study 29382675 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet-delivered computerised cognitive-behavioural therapy (ICBT) as an adjunct to usual care (UC)
Number of subjects: 30
Study 29382675 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) alone
Number of subjects: 30
Study 25893719 — intervention group
Group type: EXPERIMENTAL
Intervention: 568 ml (1 pint) water preload
Number of subjects: 14
Study 25893719 — intervention group
Group type: COMPARATOR
Intervention: No preload (control trial)
Number of subjects: 14
Study 24975782 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac contractility modulation (CCM)
Number of subjects: 641
Study 24975782 — intervention group
Group type: COMPARATOR
Intervention: Sham treatment or usual care (Control)
Number of subjects: 641
Study 22883445 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate, 100 mg epidurally before anesthesia induction and 500 mg added to the infusion postoperatively
Number of subjects: 144
Study 22883445 — intervention group
Group type: COMPARATOR
Intervention: Normal saline, 5 mL epidurally before anesthesia induction
Number of subjects: 144
Study 22883445 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups reported severity of pain as 1.0 (1-2) for patients with CPOP
Number of subjects: 144
Study 20567177 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol every 4 hours, up to four doses
Number of subjects: 156
Study 20567177 — intervention group
Group type: COMPARATOR
Intervention: Oral misoprostol with isosorbide mononitrate every 6 hours, up to two doses
Number of subjects: 156
Study 20567177 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol with isosorbide mononitrate
Number of subjects: 156
Study 18554954 — intervention group
Group type: EXPERIMENTAL
Intervention: Radix‐Anchor titanium posts
Number of subjects: 30
Study 18554954 — intervention group
Group type: COMPARATOR
Intervention: Carbon fiber posts
Number of subjects: 30
Study 18554954 — intervention group
Group type: COMPARATOR
Intervention: Glass fiber posts
Number of subjects: 30
Study 15741421 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin 80 mg/day
Number of subjects: 0
Study 15741421 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet/lifestyle counseling plus immediate fluvastatin 80 mg/day
Number of subjects: 0
Study 15741421 — intervention group
Group type: COMPARATOR
Intervention: Diet/lifestyle counseling only, with initiation of fluvastatin 80 mg/day following occurrence of future nonfatal MACE
Number of subjects: 0
Study 12855211 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced gender- and culturally specific HIV intervention
Number of subjects: 333
Study 12855211 — intervention group
Group type: COMPARATOR
Intervention: NIDA standard condition
Number of subjects: 333
Study 12855211 — intervention group
Group type: EXPERIMENTAL
Intervention: Crack smoking only group
Number of subjects: 333
Study 12855211 — intervention group
Group type: EXPERIMENTAL
Intervention: IDU only group
Number of subjects: 333